Updated Jul 16, 2026
George Simeon has filed 3 SEC Form 4 filings across 3 companies in the last 90 days — buying. Lifetime open-market purchases: $51.50M. Historical track record: 4/5 stars across 3 tracked purchases.
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★★☆ (4/5) |
|---|---|
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 10000% |
| 90-day win rate | 10000% |
| Avg 5-day return | +1848.02% |
| Avg 30-day return | +832.43% |
| Avg 90-day return | +2582.52% |
| Best 30-day return | +832.43% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-07-16 | CRSP | CRISPR Therapeutics AG | P — Open-market purchase | 961.0K | $52.03 | $50.00M |
| 2025-07-16 | CRSP | CRISPR Therapeutics AG | P — Open-market purchase | 22.3K | $52.03 | $1.16M |
| 2025-07-16 | CRSP | CRISPR Therapeutics AG | P — Open-market purchase | 6.5K | $52.03 | $339K |
George Simeon is a corporate insider — currently tracked as Insider of Design Therapeutics, Inc. (DSGN). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 3 open-market purchases ($51.50M) and 0 open-market sales () across all tracked filings.
Across 3 tracked purchases, George Simeon averaged +832.4% avg 30-day return with a 10000% 30-day win rate. InsiderAlpha rates the track record at 4/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live George Simeon profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.